Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)

Chang Gung Medical Foundation.Linkou Branch ( Site 1902), Taoyuan District

NATIONAL CHENG-KUNG UNI. HOSP. ( Site 1904), Tainan City

Centro de Educación Médica e Investigaciones Clínicas (CEMIC)-Medical Oncology ( Site 0303), Buenos Aires

Rigshospitalet ( Site 0702), Copenhagen

Herlev and Gentofte Hospital-Department of Oncology ( Site 0704), Copenhagen

Epworth Freemasons ( Site 1506), Melbourne

Western Health-Sunshine & Footscray Hospitals ( Site 1501), St Albans

Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si, Brisbane

Gallipoli Medical Research Foundation-GMRF CTU ( Site 1500), Greenslopes

Odense Universitetshospital ( Site 0700), Odense

The Queen Elizabeth Hospital-Cancer Clinical Trials ( Site 1503), Woodville

Hollywood Private Hospital-Medical Oncology ( Site 1507), Perth

National Taiwan University Hospital ( Site 1900), Taipei

Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0901), Berlin

Taipei Veterans General Hospital-Oncology ( Site 1901), Taipei

Thomas Jefferson University - Clinical Trials Office ( Site 0027), Philadelphia

MFSMC-HJWCI-Oncology Research ( Site 0012), Baltimore

MedStar Good Samaritan Hospital-Oncology Research ( Site 0038), Baltimore

Trakya University-Oncology ( Site 1303), Edirne

Inova Schar Cancer Institute ( Site 0022), Fairfax

Asklepios Altona-Oncology ( Site 0903), Hamburg

Blue Ridge Cancer Care ( Site 0036), Roanoke

HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON ( Site 1205), Madrid

Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0021), Marietta

Hospital Universitario Central de Asturias-Digestive ( Site 1200), Oviedo

Onkodok GmbH ( Site 0907), Gütersloh

Acıbadem Maslak Hastanesi ( Site 1307), Istanbul

Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1300), Istanbul

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1301), Istanbul

Ege University Medicine of Faculty-Medical Oncology ( Site 1305), Izmir

Hospital Universitario Marqués de Valdecilla ( Site 1201), Santander

China Medical University Hospital-Surgical Department ( Site 1903), Taichung

Hospital Universitario Virgen de Valme-Departamento de Oncologia ( Site 1207), Seville

İnönü Üniversitesi Turgut Özal Tıp Merkezi ( Site 1306), Malatya

Henry Ford Hospital ( Site 0024), Detroit

St. Vincent Frontier Cancer Center ( Site 0005), Billings

University of Chicago Medical Center-Medicine - Section of Hematology/Oncology - Gastrointestinal P, Chicago

Klinikum am Steinenberg-Kreiskliniken Reutlingen GmbH ( Site 0908), Reutlingen

klinikum rechts der isar der technischen universität münchen-Klinik und Poliklinik für Innere Mediz, Munich

Pacific Cancer Care ( Site 0031), Monterey

Providence Portland Medical Center ( Site 0019), Portland

Northwest Medical Specialties, PLLC ( Site 0033), Tacoma

The National Medico-Surgical Center N.I. Pirogov ( Site 1102), Moscow

Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF ( Site 1107), Moscow

"First Moscow State Medical University I.M. Sechenov-Interhospital Institution Health Management (", Moscow

SHBI Leningrad Regional Clinical Oncology Dispensary-Clinical Trials Department ( Site 1111), Saint Petersburg

Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 1100), Saint Petersburg

Sir Run Run Shaw Hospital-Medical Oncology ( Site 1606), Hangzhou

GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 1109), Ufa

SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 1600), Guangzhou

The First People's Hospital of Foshan-Gastrointestinal oncology ( Site 1604), Foshan

SVERDLOVSK REGIONAL ONCOLOGY DISPENSARY ( Site 1108), Yekaterinburg

Kanagawa cancer center ( Site 1705), Yokohama

Rambam Health Care Campus-Oncology ( Site 0800), Haifa

Aichi Cancer Center Hospital ( Site 1701), Nagoya

Sheba Medical Center ( Site 0803), Ramat Gan

Sourasky Medical Center-Oncology ( Site 0801), Tel Aviv

Shaare Zedek Medical Center-Oncology ( Site 0804), Jerusalem

Hadassah Medical Center-Oncology ( Site 0802), Jerusalem

Hospital Británico de Buenos Aires-Oncology ( Site 0308), Ciudad Autónoma de Buenos Aires

Fundación favaloro para la Docencia e Investigación Médica-Oncología ( Site 0301), Buenos Aires

Instituto de Oncología de Rosario ( Site 0305), Rosario

IDIM - Instituto de Diagnóstico e Investigaciones Metabólicas ( Site 0300), Buenos Aires

Cross Cancer Institute-Department of Medical Oncology ( Site 0207), Edmonton

NSHA-QEII Health Sciences Centre-Dickson Bldg-Dept. of Medical Oncology ( Site 0200), Halifax

Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0205), Hamilton

North York General Hospital ( Site 0206), Toronto

CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0211), Montreal

CHU de Quebec - Université Laval - Hotel Dieu de Quebec-Hemato-Dermato-Gyneco-Oncology ( Site 0203), Québec

Vejle Sygehus-Department of Oncology ( Site 0701), Vejle

National Cancer Center Hospital East ( Site 1700), Kashiwa

Kobe City Medical Center General Hospital ( Site 1707), Kobe

Kagawa University Hospital ( Site 1708), Kita

Kindai University Hospital- Osakasayama Campus-Medical Oncology ( Site 1704), Sayama

Saitama Prefectural Cancer Center ( Site 1703), Ina-machi

Shizuoka Cancer Center ( Site 1706), Nakatogari

National Hospital Organization Kyushu Cancer Center ( Site 1709), Fukuoka

National Cancer Center Hospital ( Site 1702), Tokyo

Japanese Foundation for Cancer Research-GI Oncology ( Site 1710), Tokyo

Korea University Anam Hospital ( Site 1806), Seoul

Seoul National University Hospital-Internal Medicine ( Site 1800), Seoul

Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1801), Seoul

Asan Medical Center ( Site 1803), Seoul

Samsung Medical Center-Division of Hematology/Oncology ( Site 1804), Seoul

The Catholic Univ. of Korea Seoul St. Mary's Hospital ( Site 1802), Seoul

Hospital Universitari Vall d'Hebron-Oncology ( Site 1204), Barcelona

Hacettepe Universitesi-oncology hospital ( Site 1302), Ankara

Memorial Ankara Hastanesi-Medical Oncology ( Site 1304), Ankara

Addenbrooke's Hospital ( Site 1407), Cambridge

UCLH-Cancer Clinical Trials Unit ( Site 1400), London

Guy's & St Thomas' NHS Foundation Trust ( Site 1404), London

ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 1403), London

Western General Hospital ( Site 1401), Edinburgh

Royal Marsden Hospital (Sutton) ( Site 1409), London

The Christie-Medical Oncology ( Site 1411), Manchester